Generic pharmaceutical manufacturer
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | APOTEX CORP. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $220,000 | |
| 2026 | APOTEX CORP. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $730,000 | |
| 2026 | APOTEX CORP. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $730,000 | |
| 2025 | APOTEX CORP. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $260,000 | |
| 2025 | APOTEX CORP. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $310,000 | |
| 2025 | APOTEX CORP. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $300,000 | |
| 2025 | APOTEX CORP. |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— | $810,000 | |
| 2024 | APOTEX CORP. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
— | $220,000 | |
| 2024 | APOTEX CORP. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | $160,000 | |
| 2024 | APOTEX CORP. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
— | $160,000 |
| Client | Filings | Total Income |
|---|---|---|
| APOTEX CORP. | 84 | — |
| Name | Disclosed Prior Position |
|---|---|
| STEVEN GIULI | N/A |
| REILLY O'CONNOR | N/A |